Search research articles
Contact Us
Filters
Showing results (61-70 of 305) with videos related to
Page
of 31
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 8, 2015
Meta-analysis of expression of hepatic organic anion-transporting polypeptide (OATP) transporters in cellular systems relative to human liver tissue
Justine Badée, Brahim Achour, Amin Rostami-Hodjegan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2019
Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling
Kosuke Doki, Sibylle Neuhoff, Amin Rostami-Hodjegan, et al.
RSC Advances
|
May 2, 2022
Aerobic oxidative synthesis of quinazolinones and benzothiazoles in the presence of laccase/DDQ as a bioinspired cooperative catalytic system under mild conditions
Nadia Ghorashi, Zahra Shokri, Reza Moradi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 26, 2015
Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques
Hajar Al Feteisi, Brahim Achour, Amin Rostami-Hodjegan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 11, 2003
The effects of dose staggering on metabolic drug-drug interactions
Jiansong Yang, Maria Kjellsson, Amin Rostami-Hodjegan, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 15, 2019
Characterization of CYP2B6 K262R allelic variants by quantitative allele-specific proteomics using a QconCAT standard
Jill Barber, Matthew R Russell, Amin Rostami-Hodjegan, et al.
Clinical Pharmacology and Therapeutics
|
April 13, 2019
Drug-Drug Interactions: Progress Over the Past Decade and Looking Ahead to the Future
Hartmut Derendorf, Oliver von Richter, Robert Hermann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 7, 2017
Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations
Daniel Scotcher, Christopher R Jones, Aleksandra Galetin, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 25, 2019
Accounting for inter-correlation between enzyme abundance: a simulation study to assess implications on global sensitivity analysis within physiologically-based pharmacokinetics
Nicola Melillo, Adam S Darwich, Paolo Magni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 11, 2014
Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics
Brahim Achour, Matthew R Russell, Jill Barber, et al.
Page
of 31
Search research articles
Search
Showing results (61-70 of 305) with videos related to
Sort By:
Page
of 31
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 8, 2015
Meta-analysis of expression of hepatic organic anion-transporting polypeptide (OATP) transporters in cellular systems relative to human liver tissue
Justine Badée, Brahim Achour, Amin Rostami-Hodjegan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2019
Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling
Kosuke Doki, Sibylle Neuhoff, Amin Rostami-Hodjegan, et al.
RSC Advances
|
May 2, 2022
Aerobic oxidative synthesis of quinazolinones and benzothiazoles in the presence of laccase/DDQ as a bioinspired cooperative catalytic system under mild conditions
Nadia Ghorashi, Zahra Shokri, Reza Moradi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 26, 2015
Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques
Hajar Al Feteisi, Brahim Achour, Amin Rostami-Hodjegan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 11, 2003
The effects of dose staggering on metabolic drug-drug interactions
Jiansong Yang, Maria Kjellsson, Amin Rostami-Hodjegan, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 15, 2019
Characterization of CYP2B6 K262R allelic variants by quantitative allele-specific proteomics using a QconCAT standard
Jill Barber, Matthew R Russell, Amin Rostami-Hodjegan, et al.
Clinical Pharmacology and Therapeutics
|
April 13, 2019
Drug-Drug Interactions: Progress Over the Past Decade and Looking Ahead to the Future
Hartmut Derendorf, Oliver von Richter, Robert Hermann, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 7, 2017
Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations
Daniel Scotcher, Christopher R Jones, Aleksandra Galetin, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 25, 2019
Accounting for inter-correlation between enzyme abundance: a simulation study to assess implications on global sensitivity analysis within physiologically-based pharmacokinetics
Nicola Melillo, Adam S Darwich, Paolo Magni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 11, 2014
Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics
Brahim Achour, Matthew R Russell, Jill Barber, et al.
Page
of 31